MarketBeat is an American financial media company headquartered in Sioux Falls, South Dakota, founded in 2011 by Matthew Paulson as Analyst Ratings Network before rebranding in 2015. The company operates an online platform that delivers real-time financial data, market analysis, and news, aiming to empower individual investors with tools to make informed trading decisions.
Tesla's thin auto margins and negative free cash flow are pressuring its stock as investors await Robotaxi deployment data to justify its 300x earnings multiple.
Chipmos Technologies (NASDAQ:IMOS) reported second-quarter revenue at its highest level since 2014, with stronger pricing, product mix and factory utilization lifting profitability as demand continued to exceed available capacity, Chairman and President S.J. Cheng said on the company’s 2026 semi-ann
Ituran Location and Control (NASDAQ:ITRN) reported record second-quarter revenue and profitability for 2026, driven by growth in recurring subscription revenue, subscriber additions and expanding original equipment manufacturer relationships.
Revenue for the quarter rose 21% year over year to $104.
BioMarin Pharmaceutical (NASDAQ:BMRN) outlined its growth strategy, integration plans for Amicus Therapeutics and pipeline priorities during a Canaccord discussion with Chief Financial Officer Brian Mueller.
Mueller described BioMarin as one of the largest rare-disease-focused biopharmaceutical com
Eastern (NASDAQ:EML) reported lower second-quarter sales and adjusted earnings from continuing operations, while management pointed to a sharply higher backlog, improving heavy-truck demand and its newly acquired aerospace and defense businesses as support for a stronger second half of fiscal 2026.
National Vision (NASDAQ:EYE) reported second-quarter 2026 revenue growth and improved profitability as higher average ticket sales and premium product attachment offset lower customer traffic, including temporary disruption from an e-commerce platform transition.
Net revenue rose 2.5% to $499 milli
Global-e Online (NASDAQ:GLBE) reported second-quarter 2026 results that exceeded its prior guidance ranges, citing strong same-store sales, merchant launches and promotional activity. The company raised its full-year outlook for gross merchandise value, revenue and adjusted EBITDA and included expec
Anterix (NASDAQ:ATEX) said it is seeing accelerating interest in its licensed low-band spectrum portfolio as demand grows among utilities, wireless providers and satellite connectivity companies. The company also reported first-quarter fiscal 2027 revenue of $2 million, an approximately $11 million
Altimmune (NASDAQ:ALT) said it has initiated patient enrollment in its global Phase III PERFORMA trial of pemvidutide for metabolic dysfunction-associated steatohepatitis, or MASH, while advancing plans for later-stage development in alcohol use disorder, or AUD.
Chairman and Chief Executive Office
Aquestive Therapeutics (NASDAQ:AQST) said it plans to resubmit its new drug application for Anaphylm, its epinephrine sublingual film candidate for type 1 allergic reactions including anaphylaxis, before the end of the third quarter after completing studies requested by the U.S. Food and Drug Admini
Bilfinger (ETR:GBF) reported higher second-quarter revenue and earnings per share while citing delays in customer spending and temporary underutilization related to market uncertainty. The industrial services company confirmed its 2026 outlook, though it said it now expects to land at the lower end
Hims & Hers topped Q2 revenue estimates and raised guidance, but missed EPS forecasts, posted a wider net loss, and faces an FTC lawsuit, leaving Wall Street cautious with a Hold rating.
Cameco-backed Westinghouse Electric has filed confidentially for a potential IPO, a move that could ease Cameco's debt load and boost investor interest in nuclear stocks like NuScale Power and Fluor.
ASP Isotopes (NASDAQ:ASPI) outlined plans to expand its isotope production, radiopharmacy and helium businesses during Canaccord Genuity’s 46th Annual Growth Conference, with commercial deliveries of several stable isotopes targeted for the second half of 2026.
Chief Commercial Officer Viktor Petko
Annexon (NASDAQ:ANNX) said it expanded its pivotal ARCHER II trial of vonaprument in geographic atrophy, adding an independent 24-month dual primary endpoint alongside the study’s existing 15-month primary endpoint. The company said it remains confident in a planned fourth-quarter assessment of the
Humacyte (NASDAQ:HUMA) reported second-quarter commercial sales growth while outlining plans to expand adoption of its SYMVESS vascular repair product, submit a supplemental biologics license application for dialysis access and begin a first-in-human coronary bypass study.
Commercial sales totaled
Boyd Group Services (TSE:BYD) reported second-quarter 2026 revenue above $1 billion for the first time, as the company expanded its footprint, integrated Joe Hudson’s Collision Center and advanced its Project 360 cost-transformation program.
Revenue rose 30% year over year to $1.013 billion, while
Acumen Pharmaceuticals (NASDAQ:ABOS) said it remains on track to report top-line results late in 2026 from its Phase II ALTITUDE-AD study of sabirnetug, an investigational antibody designed to selectively target synaptotoxic amyloid-beta oligomers in early Alzheimer’s disease.
Chief Executive Offic
Fastly shares jumped 27% after strong Q2 revenue and margin growth prompted analyst price target hikes and heavy institutional buying, though its high valuation remains a key risk.
Cardiol Therapeutics (NASDAQ:CRDL) is advancing its synthetic, pharmaceutical-grade cannabidiol formulation, CardiolRx, in a pivotal Phase III trial for recurrent pericarditis, with management describing the program as a key step toward a potential new drug application.
Speaking at a Canaccord Genu
Paramount Skydance's 30-film theatrical guarantee could stabilize cinema chains like AMC, but the plan hinges on its Warner Bros. Discovery merger surviving a March 2027 antitrust trial.
Coincheck Group (NASDAQ:CNCK) is positioning its business around institutional crypto infrastructure, execution and asset management as regulatory developments in Japan and other markets broaden access to digital assets, Chief Executive Officer Pascal St-Jean said during a KeyBanc discussion.
St-Je
Hill & Smith (LON:HILS) reported a strong first-half performance for 2026, led by double-digit growth in its U.S. operations and prompting the group to raise its full-year operating profit expectations.
Revenue reached $607 million, up 5% on an organic constant-currency basis, while underlying oper
Clene (NASDAQ:CLNN) said it is preparing to submit a new drug application, or NDA, in early fourth quarter for CNM-Au8 as a potential treatment for amyotrophic lateral sclerosis, following a series of meetings with the U.S. Food and Drug Administration.
President and CEO Rob Etherington said the co
Balfour Beatty (LON:BBY) reported higher first-half revenue, profit and cash generation for 2026, citing growth in U.S. buildings and U.K. power transmission as well as an improved performance in U.S. construction.
Group Chief Executive Philip Hoare said the company delivered “profitable growth and
Jenoptik (ETR:JEN) reported a return to revenue growth and a sharp improvement in profitability in the first half of 2026, supported by demand in its semiconductor-focused operations and strong order activity in Biophotonics. The company also raised the specificity of its full-year outlook, forecast
C.H. Robinson Worldwide (NASDAQ:CHRW) executives said the company plans to appeal a large jury verdict tied to a fatal accident in Dallas, while maintaining that the outcome will not alter its operating strategy, capital allocation priorities or outlook for its brokerage business.
Speaking at the C
K+S Aktiengesellschaft (ETR:SDF) raised its full-year 2026 outlook after second-quarter EBITDA rose significantly from the prior-year period, supported by higher average selling prices, stronger volumes and cost discipline.
CEO Christian H. Meyer said second-quarter EBITDA reached approximately €17
CLS (LON:CLI) reported lower first-half earnings as property disposals, tenant departures and valuation declines weighed on results, while the office investor continued its program of asset sales, debt reduction and refinancing.
Chief Executive Fredrik Widlund said the company faces “near-term earn
Evoke (LON:EVOK) reported stable first-half revenue and lower adjusted EBITDA as increased gaming duties, particularly in the U.K., added a £46 million year-on-year cost headwind. Management said mitigation efforts, including more efficient marketing, cost savings and retail estate changes, offset m
Check Point Software Technologies (NASDAQ:CHKP) sees 2027 as a potentially significant year for artificial intelligence-related cybersecurity spending as customers move from experimentation toward more deliberate budgeting, according to Global Head of Investor Relations Kip Meintzer.
Speaking at an
Bechtle (ETR:BC8) reported double-digit growth across most key metrics in the second quarter and first half of 2026, prompting the IT services provider to raise its full-year outlook despite what management described as continued challenging market conditions.
Chief Executive Officer Thomas Olemotz
Canopy Growth (NASDAQ:CGC) is positioning itself for further expansion in medical cannabis, European markets and Canadian recreational cannabis after restructuring operations, reducing costs and acquiring MTL Cannabis, President and CEO Luc Mongeau said during a Canaccord Genuity presentation.
Mong
Central Garden & Pet (NASDAQ:CENT) executives said the company is entering a period of record profitability, expanding margins and increased acquisition activity as it simplifies its operating structure and pursues growth in pet and garden products.
Speaking at Canaccord’s 46th Annual Growth Confer
Brenntag (ETR:BNR) reported a 41% year-over-year increase in second-quarter operating EBITDA to €463 million, citing stronger commercial execution, pricing discipline and accelerating savings from its cost-reduction program. Group revenue rose 11% to €4.3 billion, while operating gross profit increa
TDS reported second-quarter progress in its fiber expansion and tower infrastructure operations, while updating 2026 guidance for both TDS Telecom and Array Digital Infrastructure (NYSE:AD). Management also said it would not provide further updates or take questions regarding TDS’s pending proposal
Cogent Communications (NASDAQ:CCOI) Chief Executive Officer Dave Schaeffer said investor concerns about the company’s debt refinancing and continued revenue declines in its acquired Sprint business were key factors behind recent pressure on its shares.
Speaking at a TD Cowen conference, Schaeffer s
Beachbody (NASDAQ:BODI) Executive Chairman Mark Goldston outlined the company’s turnaround progress, retail expansion plans and product pipeline at a Canaccord consumer conference, saying the company has shifted away from its former multilevel marketing structure toward a direct-to-consumer and reta
Pet Valu (TSE:PET) reported second-quarter 2026 results marked by improved profitability, continued revenue growth and further market-share gains, as the Canadian pet retailer adjusted promotions, tightened costs and benefited from supply-chain initiatives.
Revenue increased 3.6% year over year to
Bridger Aerospace Group (NASDAQ:BAER) is expanding its aerial firefighting fleet and pursuing longer-term government contracts as wildfire activity extends further into the year, Chief Executive Officer Sam Davis said during a discussion hosted by Canaccord Genuity Senior Aerospace and Defense Techn
Nexus Industrial REIT (TSE:NXR.UN) reported higher revenue, net operating income and normalized funds from operations in the second quarter of 2026, supported by occupancy gains, completed developments and acquisitions. Management also highlighted an investment-grade credit rating, a C$500 million i
Silvercorp Metals (NYSEAMERICAN:SVM) reported higher first-quarter fiscal 2027 revenue, earnings and cash flow, aided by a sharp increase in realized silver prices, even as production was affected by lower grades and temporary safety-related disruptions at its Chinese operations.
President Lon Shav
Medexus Pharmaceuticals (TSE:MDP) reported higher first-quarter fiscal 2027 revenue and adjusted EBITDA, supported by continued growth for GRAFAPEX and a stronger contribution from IXINITY, while management maintained its full-year outlook for the recently launched transplant-conditioning product.
Neo Performance Materials (TSE:NEO) reported record second-quarter results, citing higher volumes, favorable pricing and lower conversion costs across its business segments, while reaffirming expectations to reach the high end of its increased 2026 adjusted EBITDA guidance.
Adjusted EBITDA reached
High Roller Technologies (NYSEAMERICAN:ROLR) reported lower second-quarter revenue and a wider operating loss as it reduced certain legacy online casino activities while investing in the planned launch of its ROLR U.S. prediction markets platform.
Net revenue for the quarter ended June 30 fell 52%
Stereotaxis (NYSEAMERICAN:STXS) reported second-quarter 2026 revenue of $7.7 million, as growth in sales of its robotic catheter portfolio helped lift recurring revenue to a multiyear high despite lower system revenue and continued supply constraints.
Revenue declined from the prior-year quarter be
United States Antimony (NYSE:UAMY) reported lower second-quarter revenue as antimony selling prices declined sharply from a year earlier, while the company expanded volumes, built inventory for government deliveries and advanced mining and processing projects in North America.
Revenue for the quart
Grupo Supervielle (NYSE:SUPV) reported a return to profitability in the second quarter of 2026, supported by stronger net financial income, lower inflation adjustment and early improvement in credit costs, while the Argentine financial group said its workforce-reduction program has largely been comp
AtriCure (NASDAQ:ATRC) said it is seeing continued growth across its atrial fibrillation, left atrial appendage management and postsurgical pain-management businesses, supported by new product adoption, expanding procedure volumes and progress in clinical trials.
Speaking at the Canaccord Genuity G
Energy Vault (NYSE:NRGV) reported second-quarter 2026 revenue of $17.4 million, up 104% from $8.5 million a year earlier, as progress on Australian projects supported results. The energy-storage and power-infrastructure company also raised its full-year revenue outlook, citing stronger commercial ex
Owlet (NYSE:OWLT) reported record second-quarter revenue as growth in its connected baby-monitoring products, international markets and subscription business helped offset promotional pressure in the category.
Revenue for the quarter ended June 30 rose 29.9% year over year to $33.9 million, accordi
SES AI (NYSE:SES) reported second-quarter 2026 revenue of $5.1 million, up more than 40% from $3.5 million in the prior-year quarter, while reaffirming full-year revenue guidance of $30 million to $35 million. The company said revenue during the quarter included contributions from its energy storage
CAVA Group (NYSE:CAVA) reported second-quarter 2026 revenue growth of 31.3% as same-restaurant sales increased 9%, supported by 5.3% traffic growth and continued strength in new restaurant openings.
Revenue rose to $365.4 million, while net income increased to $23 million from $18.4 million in the
CI&T (NYSE:CINT) reported record second-quarter 2026 revenue of $142.8 million, with management citing continued enterprise demand for artificial intelligence deployment and the early benefits of value-based commercial models.
Revenue rose 21.9% year over year on an organic basis and increased 14.1
H&R Block (NYSE:HRB) reported fiscal 2026 revenue growth of 4.9% and adjusted earnings-per-share growth of 13.9%, as the tax-preparation company cited improved client conversion, retention and demand from more complex filers.
For the fiscal year, revenue totaled $3.95 billion, while EBITDA increase
Pangaea Logistics Solutions (NASDAQ:PANL) reported higher profitability in the second quarter of 2026 as stronger dry bulk shipping markets, fleet positioning and charter-in activity lifted time charter equivalent, or TCE, rates above prevailing market benchmarks.
Chief Executive Officer Mads Peter
B&G Foods (NYSE:BGS) reported second-quarter 2026 results that reflected its ongoing portfolio reshaping, with higher adjusted EBITDA despite lower reported sales following several divestitures.
The company posted net sales of $383.3 million, down 9.7% from $424.4 million a year earlier. B&G Foods
Wrap Technologies (NASDAQ:WRAP) reported second-quarter revenue of $2.1 million, up 103% from $1.0 million a year earlier, as the company highlighted expanding product offerings, new training services and opportunities in private security, federal markets and threat detection.
Gross profit rose 217
Arcturus Therapeutics (NASDAQ:ARCT) is positioning its mRNA platform around two rare-disease programs targeting cystic fibrosis and ornithine transcarbamylase deficiency, while its vaccine business is intended to help support therapeutic development, President and CEO Joseph Payne said during a Cana
Vinci Compass Investments (NASDAQ:VINP) reported second-quarter 2026 fee-related earnings of BRL 88.7 million, or BRL 1.35 per share, as management fees increased and the firm benefited from acquisitions and organic fundraising. The alternative asset manager’s fee-related earnings margin reached 32.
TransAct Technologies (NASDAQ:TACT) reported second-quarter net sales of $13.9 million, up slightly from $13.8 million a year earlier, as growth in its food service technology business was partially offset by tariff-related customer refund adjustments and lower reported casino and gaming revenue.
T
Super Micro Computer (NASDAQ:SMCI) reported record fiscal 2026 revenue of $39.1 billion, up 78% from $22 billion in fiscal 2025, as demand for artificial intelligence infrastructure continued to drive growth. The company also projected fiscal 2027 revenue of $65 billion to $72 billion and said it en
Taysha Gene Therapies (NASDAQ:TSHA) said it completed dosing in its REVEAL pivotal trial and ASPIRE trial for TSHA-102, its gene therapy candidate for Rett syndrome, while preparing for a potential biologics license application submission.
Chief Executive Officer Sean Nolan said the company dosed 1
Seer (NASDAQ:SEER) reported second-quarter revenue of $3.1 million, down from $4.1 million a year earlier but up from $2.8 million in the first quarter, as the proteomics company cited continued pressure on academic and government funding and longer sales cycles among some commercial customers.
Chi
Apyx Medical (NASDAQ:APYX) is positioning its Renuvion technology and newly launched AYON Body Contouring System to address growing demand for surgical aesthetic procedures, a trend CEO Charlie Goodwin said has been reshaped by the increasing use of GLP-1 weight-loss drugs.
Speaking at the Canaccor
RideNow Group (NASDAQ:RDNW) reported second-quarter 2026 same-store revenue growth and a double-digit increase in adjusted EBITDA, as management said operational improvements and cost discipline continued to support its turnaround efforts.
Same-store revenue reached $291.5 million, up 3% from $282.
Red Violet (NASDAQ:RDVT) reported record second-quarter results for 2026, with revenue, profitability and operating cash flow all reaching new highs as demand for identity intelligence solutions increased across its customer base.
Revenue rose 23% year over year to $26.7 million, while adjusted EBI
QuickLogic (NASDAQ:QUIK) reported second-quarter fiscal 2026 revenue of $5.5 million, up 48.7% from the prior-year period and 8.5% sequentially, as growth in new product revenue offset a smaller mature-product business. Management said a delayed extension of an existing customer contract pushed reve
Quantinuum (NASDAQ:QNT) reported second-quarter 2026 revenue of $8 million, up 279% from the prior-year period, in its first earnings call as a public company following its June initial public offering.
Chief Executive Officer Raj Hazra said the company is pursuing leadership across quantum hardwar
NeuroPace (NASDAQ:NPCE) reported second-quarter revenue growth driven by continued adoption of its RNS System for adult focal epilepsy, while raising its full-year revenue and adjusted EBITDA outlook. The company also said it is pursuing additional discussions with the U.S. Food and Drug Administrat
Optex Systems (NASDAQ:OPXS) reported higher third-quarter and nine-month revenue, operating income and net income, supported by increased periscope production and stronger demand for military laser filters, while management said recently announced awards lifted backlog to $45 million as of Aug. 5.
NextNav (NASDAQ:NN) said its second-quarter actions strengthened its balance sheet, expanded liquidity and advanced partnerships and technical validation efforts as the company continues to pursue regulatory approval for its proposed 900 MHz terrestrial positioning, navigation and timing network.
C
National CineMedia (NASDAQ:NCMI) reported higher second-quarter revenue and advertising sales as theater attendance increased, while also announcing a definitive agreement to acquire digital elevator and lobby advertising operator Captivate for an enterprise value of $275 million.
Chief Executive O
Mobia Medical (NASDAQ:MOBI) reported second-quarter revenue of $13.5 million, up 102% from $6.7 million a year earlier, as adoption of its Vivistim paired vagus nerve stimulation therapy expanded across new and existing stroke-care programs.
The company, which completed its initial public offering
